Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Sernova News on Trading Activity :)

<< Previous

Bullboard Posts

Next >>

Post by jwalliscaon Dec 11, 2020 1:46pm

190 Views

Post# 32089514

Sernova News on Trading Activity :)

I was actually trying to contact Sernova (but couldn't get through) to ask when the company would be asked by the exchange what's going on!

I provide the news below and a link. I have made Bold Red two words.

Recently, there has been multiple hints in news releases and interviews, ergo Sernova is covered by denying even though it's letting the cat out of the bag!

Sernova on Stock Trading Activity - Link

Yes, where there's smoke, there's fire!

jwall

2020-12-11 13:05 ET - News Release

Mr. Dominic Gray reports

SERNOVA CORP. RESPONDS TO MARKET ACTIVITY

At the request of the Investment Industry Regulatory Organization of Canada, Sernova Corp. has confirmed that the company's management is unaware of any material or undisclosed information or change in the company's operations that would account for the recent increase in price and market activity.

About Sernova Corp.

Sernova is developing regenerative medicine therapeutic technologies using a medical device and immune-protected therapeutic cells (human donor cells, corrected human cells and stem-cell-derived cells) to improve the treatment and quality of life of people with chronic metabolic diseases, such as: insulin-dependent diabetes, blood disorders, including hemophilia, and other diseases treated through the replacement of proteins or hormones missing or in short supply within the body.

<< Previous

Bullboard Posts

Next >>

Globex Mining: Unveiling Québec’s hidden gold and lithium treasures